{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T07:10:39Z","timestamp":1685085039602},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.eimc.2009.04.003","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T08:56:19Z","timestamp":1249376179000},"page":"239-244","source":"Crossref","is-referenced-by-count":1,"title":["Usar rifampicina m\u00e1s pirazinamida en profilaxis antituberculosa no incrementa el riesgo de hepatotoxicidad grave en pacientes infectados por virus de la inmunodeficiencia humana: metaan\u00e1lisis de ensayos cl\u00ednicos aleatorizados y controlados"],"prefix":"10.1016","volume":"28","author":[{"given":"\u00c1ngela","family":"Camacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00e9s","family":"P\u00e9rez-Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Natera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milagros","family":"Garc\u00eda-L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jos\u00e9","family":"Cast\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Kindel\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2009.04.003_bib1","first-page":"385","article-title":"Preventive therapy against tuberculosis in people living with HIV","volume":"74","year":"1999","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.eimc.2009.04.003_bib2","doi-asserted-by":"crossref","unstructured":"Rivero A, Santos J, M\u00e1rquez M, Esteve A, Pinedo A, Palacios R, et al. Factors related with the incubation period of multidrug-resistant tuberculosis in an outbreak among HIV infected patients. En: 40th Interscience Conference On Antimicrobial Agents And Chemotherapy; 2000; Toronto, Canad\u00e1. 2000.","DOI":"10.1016\/S0163-4453(00)80024-9"},{"key":"10.1016\/j.eimc.2009.04.003_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/317547","article-title":"High rate of tuberculosis reinfection during a nosocomial outbreak of multidrug-resistant tuberculosis caused by Mycobacterium bovis strain B","volume":"32","author":"Rivero","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2009.04.003_bib4","unstructured":"Ribera E, Orcau A, Garc\u00eda de Olalla P, S\u00e1nchez P, Cayl\u00e0 JA. Epidemiolog\u00eda de la tuberculosis en pacientes infectados por el VIH. En: Rivero A, editor. Tuberculosis en pacientes infectados por el VIH. Sevilla: Editorial Tafics; 2004. p. 17\u201344."},{"key":"10.1016\/j.eimc.2009.04.003_bib5","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199903110-00009","article-title":"Isoniazid prophylaxis for tuberculosis in HIV infection: A meta-analysis of randomized controlled trials","volume":"13","author":"Bucher","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2009.04.003_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJM198903023200901","article-title":"A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection","volume":"320","author":"Selwyn","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2009.04.003_bib7","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00002030-199310000-00007","article-title":"A prospective study of the risk of tuberculosis among HIV-infected patients","volume":"7","author":"Guelar","year":"1993","journal-title":"AIDS"},{"key":"10.1016\/j.eimc.2009.04.003_bib8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archinte.156.8.889","article-title":"Effect of isoniazid chemoprophylaxis on HIV-related mycobacterial disease","volume":"156","author":"Graham","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eimc.2009.04.003_bib9","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199709183371201","article-title":"A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University. Research Collaboration","volume":"337","author":"Whalen","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2009.04.003_bib10","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0140-6736(93)91817-6","article-title":"Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection","volume":"342","author":"Pape","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2009.04.003_bib11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1157\/13048575","article-title":"Ensayo cl\u00ednico aleatorizado de tres pautas de quimioprofilaxis para prevenir la tuberculosis en pacientes infectados por el VIH con anergia cut\u00e1nea","volume":"21","author":"Rivero","year":"2003","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.04.003_bib12","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(97)06532-X","article-title":"Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection","volume":"351","author":"Halsey","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.eimc.2009.04.003_bib13","unstructured":"Rivero A, Camacho A, Gallo M. Terapia preventiva antituberculosa en pacientes infectados por el VIH. En: Rivero A, editor. Tuberculosis en pacientes infectados por el VIH. Sevilla: Editorial Tafics; 2004. p. 181\u2013221."},{"key":"10.1016\/j.eimc.2009.04.003_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.283.11.1445","article-title":"Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: An international randomized trial","volume":"283","author":"Gordin","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.eimc.2009.04.003_bib15","first-page":"1","article-title":"Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: Principles of therapy and revised recommendations","volume":"47","year":"1998","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2009.04.003_bib16","first-page":"733","article-title":"Fatal and severe liver injuries associated with rifampin and pyrazinamide for latent tuberculosis infection, and revisions in American Thoracic Society\/CDC Recomendations","volume":"50","year":"2001","journal-title":"MMWR"},{"key":"10.1016\/j.eimc.2009.04.003_bib17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.7326\/0003-4819-137-8-200210150-00007","article-title":"Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A multicenter clinical trial","volume":"137","author":"Jasmer","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eimc.2009.04.003_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: Is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.eimc.2009.04.003_bib19","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1097\/00002030-199818000-00014","article-title":"Twice weekly tuberculosis preventive therapy in HIV infection in Zambia","volume":"12","author":"Mwinga","year":"1998","journal-title":"Aids"},{"key":"10.1016\/j.eimc.2009.04.003_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1157\/13102265","article-title":"Ensayo cl\u00ednico aleatorizado para evaluar tres pautas cortas de tratamiento de la infecci\u00f3n latente tuberculosa en pacientes infectados por el VIH","volume":"25","author":"Rivero","year":"2007","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.eimc.2009.04.003_bib21","first-page":"1080","article-title":"Rifampin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: A metan\u00e1lisis","volume":"10","author":"Gao","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.eimc.2009.04.003_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eimc.2009.04.003_bib23","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/00126334-200309011-00005","article-title":"A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients","volume":"34","author":"Stern","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.eimc.2009.04.003_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jac\/dkl524","article-title":"Liver toxicity induced by non-nucleoside reverse transcriptase inhibitors","volume":"59","author":"Rivero","year":"2007","journal-title":"JAC"},{"key":"10.1016\/j.eimc.2009.04.003_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1468-1293.2007.00533.x","article-title":"European AIDS Clinical Society (EACS) guidelines for the clinical management an treatment of HIV-infected adults","volume":"9","author":"Clumeck","year":"2008","journal-title":"HIV Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09003358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X09003358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T06:38:39Z","timestamp":1685083119000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X09003358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0213005X09003358"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2009.04.003","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}